Trial intelligence / Profile preview

Biapenem versus meropenem for bacterial lower respiratory tract and urinary tract infections

ChiCTR-TRC-12001943Phase 2Completed

Sponsor
West China Hospital of Sichuan University
Start
Jan 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, single-blind trial in pulmonary infection and urinary tract infection (UTI) comparing Biapenem group with Meropenem control group (2 arms). Primary endpoint: Clinical efficacy. Started Jan 2009; status: completed.

02

Drugs

biapenemmeropenem
03

Conditions

pulmonary infectionurinary tract infection (UTI)

Beyond the preview

Go deeper on ChiCTR-TRC-12001943.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-12001943.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call